Purified anti-β-Amyloid, 1-16 Antibody (Previously Covance catalog# SIG-39320)

Pricing & Availability
Clone
6E10 (See other available formats)
Regulatory Status
RUO
Other Names
AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2, Amyloid beta A4 protein, preA4, protease, peptidase nexin-II, beta-amyloid peptide, alzheimer disease amyloid protein, cerebral vascular amyloid peptide, APP, Amyloid Precursor Protein
Previously
Signet Catalog# 9320-02
Signet Catalog# 9320-05
Signet Catalog# 9320-10
Covance Catalog# SIG-39320
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
A_6E10_PURE_betaAmyloid_1-16_WB_050818
Western blot of purified anti-β-amyloid, 1-16 antibody (clone 6E10). Lane 1: Molecular weight marker; Lane 2: 50 ng of the human Aβ1-40 peptide; Lane 3: 50 ng of the Aβ1-42 peptide; Lane 4: 50 ng of the recombinant human APP751 protein; Lane 5: 20µg of the human brain lysate; Lane 6: 50 ng of the rodent Aβ1-42 peptide. The blot was incubated with 1 µg/mL of the primary antibody overnight at 4°C, followed by incubation with the HRP goat anti-mouse IgG antibody (Cat. No. 405306). Enhanced chemiluminescence was used as the detection system.
  • A_6E10_PURE_betaAmyloid_1-16_WB_050818
    Western blot of purified anti-β-amyloid, 1-16 antibody (clone 6E10). Lane 1: Molecular weight marker; Lane 2: 50 ng of the human Aβ1-40 peptide; Lane 3: 50 ng of the Aβ1-42 peptide; Lane 4: 50 ng of the recombinant human APP751 protein; Lane 5: 20µg of the human brain lysate; Lane 6: 50 ng of the rodent Aβ1-42 peptide. The blot was incubated with 1 µg/mL of the primary antibody overnight at 4°C, followed by incubation with the HRP goat anti-mouse IgG antibody (Cat. No. 405306). Enhanced chemiluminescence was used as the detection system.
  • B_6E10_PURE_betaAmyloid_1-16_DirectELISA_050818
    Direct ELISA of purified anti-β-amyloid 1-16 (clone 6E10) antibody binding to the plate-immobilized human Aβ1-40 and the recombinant human APP751. ELISA was performed by coating the wells with 100 ng of peptide or recombinant protein. The wells were then incubated with the primary antibody at 37°C for 45 minutes, followed by incubation with HRP labeled goat anti-mouse IgG secondary antibody. TMB (3, 3', 5, 5' tetramethylbenzidine, Cat. No. 421501) was used as the detection system.
  • C_6E10_PURE_betaAmyloid_1-16_IHCP_050818
    IHC staining of purified anti-β-Amyloid, 1-16 antibody (clone 6E10) on the formalin-fixed paraffin-embedded normal human (left panel) and Alzheimer’s disease (right panel) brain tissues. Following antigen retrieval using 70% formic acid for 20 minutes, the tissues were incubated with 1µg/mL of the primary antibody for 1 hour at room temperature. BioLegend’s Ultra-Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The images were captured with a 40X objective. Scale bar: 50 µm
Compare all formats
Cat # Size Price Save
803004 25 µL ¥22,050
803001 200 µL ¥109,200
803002 500 µL ¥213,360
803003 1 mL ¥350,910
Description

Alzheimer's disease is characterized by the accumulation of aggregated Aβ peptides in senile plaques and vascular deposits. Aβ peptides are derived from amyloid precursor proteins (APP) through sequential proteolytic cleavage of APP by β-secretases and γ-secretases generating diverse Aβ species. Aβ can aggregate to form soluble oligomeric species and insoluble fibrillar or amorphous assemblies. Some forms of the aggregated peptides are toxic to neurons.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution (no preservatives or carrier proteins).
Preparation
The antibody was purified by affinity chromatography.
Concentration
1 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check your vial or your CoA to find the most accurate storage condition for this antibody.
Application

WB - Quality tested
Direct ELISA, IHC-P Verified
IHC-F, EM, ICC -  Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by western blotting. For western blotting, the suggested use of this reagent is 1 µg/mL. For Direct ELISA, the suggested use of this reagent is 0.002 - 0.02 µg/mL. For immunohistochemistry on formalin-fixed paraffin-embedded tissue sections, the suggested use of this reagent is 0.2 - 5.0 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

This antibody is reactive to amino acid residue 1-16 of beta amyloid. The epitope lies within amino acids 3-8 of beta amyloid (EFRHDS).

This antibody clone has been reported for use in immunohistochemistry of free-floating sections2,13.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Thakker DR, et al. 2009. Proc. Natl. Acad. Sci. USA. 106(11):4501-6. (IHC) PubMed
  2. Oddo S, et al. 2005. Proc. Natl. Acad. Sci. USA. 102(8):3046-51. (IHC-other) PubMed
  3. Herzig M, et al. 2004. Nat. Neuro. 7(9):954-959. (WB) PubMed
  4. Zheng Y, et al. 2012. PLoS One 6:39035. (IHC-F) PubMed
  5. Abramowksi D, et al. J Neurosci. 32:1273. (WB) PubMed
  6. Forny-Germano L, et al. 2014. J. Neurosci. 34:13629. (WB, IHC) PubMed
  7. Gowert NS, et al. 2014. PLoS One 2:e90523. (ICC, EM) PubMed
  8. Sandoval-Hernández A, et al. 2015. PLoS One. 10: 0145467. (IHC-F)
  9. Kumar R, et al. 2016. Brain. 139:174-92 (WB)
  10. Miyamoto T, et al. 2016. J. Biol. Chem. 291:1719-34. (WB)
  11. Saito S, et al. 2017. Acta Neuropathol. Commun. 5:26-9. (IHC-P) PubMed
  12. Omata Y, et al. 2016. Aging (Albany NY) 8(3):427. (IHC-P) PubMed
  13. Peng W, et al. 2016. Neurobiol. Dis. 93:215. (IHC-other) PubMed
  14. Mandler M, et al. 2015. PLoS One. e0115237. (WB, IHC, ELISA) PubMed
Product Citations
  1. Abud EM et al. 2017. Neuron. 94(2):278-293 . PubMed
  2. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  3. Eede P, et al. 2020. EMBO Rep. 21:e48530. PubMed
  4. Sogorb-Esteve A, et al. 2018. Mol Neurobiol. 55:5047. PubMed
  5. Turnbull MT, et al. 2018. Front Mol Neurosci. 11:51. PubMed
  6. Lam AB, et al. 2021. Cell Rep. 36:109753. PubMed
  7. Joly S, et al. 2021. Int J Mol Sci. 22:. PubMed
  8. Rupawala H, et al. 2022. Brain Commun. 4:fcac192. PubMed
  9. Lee NK, et al. 2020. Int J Mol Sci. :21. PubMed
  10. Hsu CN, et al. 2021. PLOS Computational Biology. 17(5):e1008967. PubMed
  11. Zhang H, et al. 2020. J Neurosci. 40:5347. PubMed
  12. Shi Y, et al. 2020. J Alzheimers Dis. 76:1375. PubMed
  13. von Saucken VE, et al. 2020. Neurobiol Dis. 145:105072. PubMed
  14. Zheng Y, et al. 2019. Brain. 142:787. PubMed
  15. Ren J, et al. 2020. Int J Clin Exp Pathol. 3.030555556. PubMed
  16. Medina CS, et al. 2019. Front Cell Neurosci. 0.889583333. PubMed
  17. Opazo P, et al. 2018. Cell Rep. 23:3137. PubMed
  18. Khan I, et al. 2018. Sci Rep. 8:12834. PubMed
  19. Roitenberg N, et al. 2018. EMBO Rep. 19. PubMed
  20. Kulas JA, et al. 2017. J Endocrinol. 235:49. PubMed
  21. Ring J, et al. 2022. EMBO Mol Med. 14:e13952. PubMed
  22. Dong Y, et al. 2020. Theranostics. 10:179. PubMed
  23. Huang Y, et al. 2021. Nat Immunol. 22:586. PubMed
  24. Crivelli SM, et al. 2021. Alzheimers Res Ther. 13:45. PubMed
  25. Rimal S, et al. 2021. Acta Neuropathol Commun. 9:169. PubMed
  26. Lee HJ, et al. 2021. Biology (Basel). 10:. PubMed
  27. Sha S, et al. 2021. Aging (Albany NY). 13:15285. PubMed
  28. Donner L, et al. 2016. Sci Signal. 9: ra52. PubMed
  29. Jeon SH, et al. 2020. Int J Mol Sci. 21:00. PubMed
  30. Doustar J, et al. 2020. Aging Cell. :e13246. PubMed
  31. Lee Y, et al. 2020. Sci Rep. 10:16144. PubMed
  32. Rocchi A, et al. 2017. PLoS Genet.. 10.1371/journal.pgen.1006962. PubMed
  33. Yang C, et al. 2017. Autophagy. :0. PubMed
  34. Finke JM, et al. 2017. Biochim Biophys Acta. 1861:2228. PubMed
  35. O'Reilly MA, et al. 2017. Theranostics. 7:3573. PubMed
  36. Ziegler–Waldkirch S, et al. 2018. EMBO J. 37:167. PubMed
  37. Baek SH, et al. 2017. J Neurosci. 37:5099. PubMed
  38. Serra–Batiste M, et al. 2018. Front Mol Biosci. 5:38. PubMed
  39. Asam K, et al. 2017. PLoS One. 12:e0189413. PubMed
  40. Beraldo FH, et al. 2019. Elife. 8:e49630. PubMed
  41. Vu HT, et al. 2017. Sci Rep. 7:40205. PubMed
  42. Lin Y, et al. 2021. Acta Neuropathol Commun. 9:102. PubMed
  43. Paasila PJ, et al. 2020. Free Neuropathol. 1:. PubMed
  44. Zhao Y, et al. 2022. Nat Commun. 13:1121. PubMed
  45. Machhi J, et al. 2022. ACS Chem Neurosci. 13:1232. PubMed
  46. Wang T, et al. 2022. Aging Dis. 13:1504. PubMed
  47. Leal NS, et al. 2020. Cells. 9:00. PubMed
  48. A Kimura, S Hata, T Suzuki 2016. J Biol Chem. 291: 24041 - 24053. PubMed
  49. Ghatak S, et al. 2020. eLife. 8:e50333.. PubMed
  50. Brozzetti L, et al. 2020. Front Neurosci. 14:145. PubMed
  51. Zhu X, et al. 2017. Aging Cell. 16:1073. PubMed
  52. Kollmer M, et al. 2019. Nat Commun. 3.722222222. PubMed
  53. Qin K, et al. 2019. Sci Rep. 6.294444444. PubMed
  54. Yang P, et al. 2019. BMC Immunol. 20:09. PubMed
  55. Bearer EL, et al. 2018. Neurobiol Aging. 70:276. PubMed
  56. Lisa Dolfe et al. 2018. Journal of Alzheimer's disease reports. 2(1):27-39 . PubMed
  57. González C, et al. 2018. Mol Psychiatry. 23:2363. PubMed
  58. Hu X, et al. 2017. Front Neuroanat. 11:45. PubMed
  59. Feng T, et al. 2017. J Biol Chem. 292:1679. PubMed
  60. Bartolotti N, et al. 2018. J Alzheimers Dis. 66:1425. PubMed
  61. Zhi D, et al. 2017. Sci Rep. 10.1038/s41598-017-11628-9. PubMed
  62. Willén K, et al. 2017. Mol Neurodegener. 10.1186/s13024-017-0203-y. PubMed
  63. Lee HY, et al. 2022. Alzheimers Res Ther. 14:177. PubMed
  64. Zheng Q, et al. 2022. J Clin Invest. 132:. PubMed
  65. Li ZF, et al. 2022. Dis Model Mech. 15:. PubMed
  66. Ding X, et al. 2021. Nat Commun. 12:2030. PubMed
  67. Huang GD, et al. 2020. Transl Psychiatry. 10:431. PubMed
  68. Koronyo-Hamaoui M, et al. 2020. Brain. 143:336. PubMed
  69. Ikonomovic MD, et al. 2020. Acta Neuropathol. 140:463. PubMed
  70. Martin L, et al. 2021. Cell Reports. 35(6):109121. PubMed
  71. Chiang ACA, et al. 2018. Am J Pathol. 188:739. PubMed
  72. Sun J, et al. 2019. Nat Commun. 10:53. PubMed
  73. Croft CL, et al. 2017. Cell Death Dis. 8:e2671. PubMed
  74. de Dios C, et al. 2019. Redox Biol. 26:101283. PubMed
  75. Reinhardt S, et al. 2018. Sci Rep. 1.25625. PubMed
  76. Zhang L, et al. 2018. Neurobiol Dis. 114:01:00. PubMed
  77. Edler MK, et al. 2018. J Comp Neurol. 526:2921. PubMed
  78. Li L, et al. 2019. Exp Neurobiol. 28:329. PubMed
  79. Gerber H, et al. 2019. Acta Neuropathol Commun. 7:13. PubMed
  80. Pera M, et al. 2017. EMBO J. 36:3356. PubMed
  81. Batarseh YS, et al. 2018. J Nutr Biochem. 55:113. PubMed
  82. Ruiz-Riquelme A, et al. 2021. Acta Neuropathol Commun. 9:83. PubMed
  83. Jang YN, et al. 2020. Neuropathol Appl Neurobiol. 47:625. PubMed
  84. Gkanatsiou E, et al. 2021. J Neurochem. 159:258. PubMed
  85. Ying J, et al. 2022. Nat Commun. 13:886. PubMed
  86. Lim JY, et al. 2021. Stem Cell Res Ther. 12:402. PubMed
  87. Jiwaji Z, et al. 2022. Nat Commun. 13:135. PubMed
  88. Sun Y, et al. 2021. Phytother Res. :. PubMed
  89. Luo Z, et al. 2022. Drug Des Devel Ther. 16:3285. PubMed
  90. Guo X, et al. 2020. Aging Dis. 1.446527778. PubMed
  91. Kirouac L et al. 2015. eNeuro. 4(2) pii: ENEURO. PubMed
  92. Bai B, et al. 2020. Neuron. 105(6):975-991.e7.. PubMed
  93. Yan T, et al. 2018. J Alzheimers Dis. 63:157. PubMed
  94. Liu D, et al. 2018. Neurobiol Aging. 70:160. PubMed
  95. Sebollela A et al. 2017. Journal of neurochemistry. 142(6):934-947 . PubMed
  96. Valls–Comamala V, et al. 2017. Oncotarget. 8:41154. PubMed
  97. Söllvander S, et al. 2018. J Neuroinflammation. 15:98. PubMed
  98. Kedia N, et al. 2017. Phys Chem Chem Phys. 19:18036. PubMed
  99. Limbocker R, et al. 2019. Nat Commun. 10:225. PubMed
  100. Kasica NP, et al. 2022. Front Aging Neurosci. 14:959326. PubMed
  101. Ghatak S, et al. 2021. Mol Psychiatry. 26:5751. PubMed
  102. Utagawa EC, et al. 2022. Acta Neuropathol Commun. 10:86. PubMed
  103. Clark AT, et al. 2022. Fluids Barriers CNS. 19:5. PubMed
  104. Sade Yazdi D, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  105. Singh CSB, et al. 2021. EBioMedicine. 71:103503. PubMed
  106. Mo D, et al. 2020. Cells. 9:00. PubMed
  107. Seo NY, et al. 2021. Frontiers in Neuroanatomy. 15:690168. PubMed
  108. Ates G, et al. 2020. Redox Biol. 101648:36. PubMed
  109. Leonetti M, et al. 2019. Sci Rep. 9:4591. PubMed
  110. Harach T, et al. 2017. Sci Rep. 7:41802. PubMed
  111. Ayaki T, et al. 2018. J Neuropathol Exp Neurol. 77:128. PubMed
  112. Paula PC, et al. 2019. Molecules. 24. PubMed
  113. Ye X et al. 2017. The Journal of Neuroscience. 37(10):2639-2655 . PubMed
  114. Colvin BA, et al. 2017. J Neurochem. 143:736. PubMed
  115. Cox LM, et al. 2019. Sci Rep. 9:17904. PubMed
  116. Fang EF, et al. 2019. Nat Neurosci. 22:401. PubMed
  117. Imanikia S, et al. 2019. Cell Rep. 28:581. PubMed
  118. Readhead B, et al. 2018. Neuron. 99:64. PubMed
  119. Huichalaf CH, et al. 2019. Hum Mol Genet. 28:2014. PubMed
  120. Vandenabeele M, et al. 2021. Acta Neuropathol Commun. 9:6. PubMed
  121. Huang W, et al. 2021. Nat Commun. 12:5659. PubMed
  122. Hugais MM, et al. 2021. MicroPubl Biol. 2021:. PubMed
  123. Uhlmann RE, et al. 2020. Nat Neurosci. 23:1580. PubMed
  124. Koh HS, et al. 2021. Int J Mol Sci. 22:. PubMed
  125. Xu B, et al. 2022. Aging Dis. 13:1293. PubMed
  126. Benbow SJ, et al. 2020. Hum Mol Genet. 495:29. PubMed
  127. Lin L, et al. 2020. Acta Neuropathol Commun. 0.470138889. PubMed
  128. Daria A, et al. 2017. EMBO J. 10.15252/embj.201694591. PubMed
  129. Cifelli J, et al. 2016. J Biol Chem. 291: 11981 - 11992. PubMed
  130. Kumar R, et al. 2016. Brain. 139: 174 - 192. PubMed
  131. Lahiri S, et al. 2019. Crit Care. 1.002083333. PubMed
  132. Imanikia S, et al. 2019. Curr Biol. 29:2322. PubMed
  133. Zysk M, et al. 2019. J Alzheimers Dis. 72:161. PubMed
  134. Shmueli MD, et al. 2017. J Biol Methods. 4:e69. PubMed
  135. Bove–Fenderson E, et al. 2017. J Biol Chem. 292:16858. PubMed
  136. Huynh TV, et al. 2017. Neuron. 96:1013. PubMed
  137. Fiock KL et al. 2019. J Comp Neurol. 528(1):108-113 . PubMed
  138. Wendeln AC, et al. 2018. Nature. 556:332. PubMed
  139. Esposito G, et al. 2019. Mar Drugs. 17. PubMed
  140. Poksay KS, et al. 2017. Front Pharmacol. 8:46. PubMed
  141. Pan RY, et al. 2019. Sci Adv. 5:eaau6328. PubMed
  142. Maharjan S, et al. 2022. Front Neurosci. 16:1025457. PubMed
  143. Li L, et al. 2022. Front Aging Neurosci. 13:770948. PubMed
  144. Mizuno Y, et al. 2022. Oxid Med Cell Longev. 2021:8635088. PubMed
  145. Zheng Q, et al. 2021. Sci Adv. 7:. PubMed
  146. Forner S, et al. 2021. Sci Data. 8:270. PubMed
  147. Xu X, et al. 2021. Protein Cell. 12:769. PubMed
  148. Montalbano M, et al. 2020. Neurobiol Dis. 146:105130. PubMed
  149. Pérez-González R, et al. 2020. FASEB J. 34:12922. PubMed
  150. Miguel JC, et al. 2021. Front Aging Neurosci. 645334:13. PubMed
  151. Park J,et al. 2017. J Radiat Res.. 10.1093/jrr/rrx045. PubMed
  152. Xia F, et al. 2017. Neuropsychopharmacology. 42:2493. PubMed
  153. Cecon E et al. 2019. Br J Pharmacol. 176(18):3475-3488 . PubMed
  154. Nobili A et al. 2017. Nature communications. 253:27:00 . PubMed
  155. Gee MS, et al. 2020. Alzheimers Res Ther. 12:45. PubMed
  156. Baik SH, et al. 2020. Cell Metabolism. 30(3):493-507. PubMed
  157. Nowicka U, et al. 2021. Elife. 10: . PubMed
  158. Chan HH, et al. 2021. Rep Biochem Mol Biol. 9:417. PubMed
  159. Pan JX, et al. 2021. Commun Biol. 4:1326. PubMed
  160. Ni W, et al. 2021. J Proteome Res. 20:4106. PubMed
  161. Emre C, et al. 2022. Commun Biol. 5:245. PubMed
  162. Lu MH, et al. 2021. Front Aging Neurosci. 650103:13. PubMed
  163. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  164. Ren JM, et al. 2020. Mol Med Rep. 2.349305556. PubMed
  165. Augé E, et al. 2017. Sci Rep. 7:41807. PubMed
  166. Li L, et al. 2020. Neural Plast. 2020:8836173. PubMed
  167. Shi H, et al. 2020. Acta Neuropathol. 139:813. PubMed
  168. Tambini MD, et al. 2020. Elife. 9:e52612. PubMed
  169. Stimmell AC, et al. 2019. Sci Rep. 1.285416667. PubMed
  170. Wang X, et al. 2017. Front Aging Neurosci. 9:157. PubMed
  171. Jo KW, et al. 2022. Alzheimers Res Ther. 14:158. PubMed
  172. Russo-Savage L, et al. 2020. Neurobiol Aging. 95:69. PubMed
  173. Sherman M, et al. 2016. J Neurosci. 36: 9647 - 9658. PubMed
  174. Hostetler E, et al. 2016. J Nucl Med. 57: 1599 - 1606. PubMed
  175. Liu D, et al. 2020. J Neuroinflammation. 0.8875. PubMed
  176. Maron R, et al. 2020. International Journal of Molecular Sciences. 21(9):. PubMed
  177. Dore K, et al. 2021. Cell Reports. 35(9):109194. PubMed
  178. Li TY, et al. 2021. Nat Aging. 165:1. PubMed
  179. Chandramowlishwaran P, et al. 2018. J Biol Chem. 293:3436. PubMed
  180. Bonds JA, et al. 2019. J Neurosci. 39:8576. PubMed
  181. Wieckowska-Gacek A, et al. 2021. Front Aging Neurosci. 13:654509. PubMed
  182. Yang Y, et al. 2022. Nat Commun. 13:159. PubMed
  183. Riad A, et al. 2020. Mol Neurobiol. 57:3803. PubMed
  184. Casali BT, et al. 2020. Neurobiol Dis. 142:104956. PubMed
  185. Yao J, et al. 2020. Cell Rep. 32:108169. PubMed
  186. Socodato R, et al. 2020. Cell Reports. 31(12):107796. PubMed
  187. Ren P, et al. 2020. Oxid Med Cell Longev. 2020:3050971. PubMed
  188. Braggin JE, et al. 2019. Ann Clin Transl Neurol. 0.779166667. PubMed
  189. Rosenberg RN, et al. 2018. Alzheimers Res Ther. 0.496527778. PubMed
  190. Kozin SA, et al. 2018. Front Neurosci. 0.859722222. PubMed
  191. Herzer S, et al. 2018. Front Mol Neurosci. 11:206. PubMed
  192. Zhang JH, et al. 2018. BMC Complement Altern Med. 18:167. PubMed
  193. Li N, et al. 2017. Curr Alzheimer Res. 14:1109. PubMed
  194. Garcia–Esparcia P, et al. 2017. Front Neurol. 8:89. PubMed
  195. Song M, et al. 2018. Genes (Basel). 9:. PubMed
  196. Flores J, et al. 2022. Cell Death Dis. 13:864. PubMed
  197. Baruch K, et al. 2016. Nat Med. 22:135-137. PubMed
  198. Farid MM, et al. 2020. Sci Rep. 10:16424. PubMed
  199. Lee SH, et al. 2020. Eneuro. . PubMed
  200. Aisling Chaney et al. 2017. Journal of neurochemistry. 144(3):318-335 . PubMed
  201. Dong ZZ, et al. 2018. Int J Ophthalmol. 11:747. PubMed
  202. Lin TW, et al. 2017. PLoS One. 12:e0174561. PubMed
  203. Plá V, et al. 2017. Front Mol Neurosci. 10:202. PubMed
  204. Chandra S, et al. 2018. J Neurosci. 38:6682. PubMed
  205. Barykin EP, et al. 2018. Front Mol Neurosci. 0.668055556. PubMed
  206. Calvo-Rodríguez M, et al. 2020. Nat Commun. 11:2146. PubMed
  207. Schmidt K, et al. 2017. Mediators Inflamm. 2017:5470831. PubMed
  208. Baglietto-Vargas D, et al. 2021. Nat Commun. 12:2421. PubMed
  209. Plowey ED, et al. 2022. Acta Neuropathol. 144:143. PubMed
  210. Barrett T, et al. 2021. J Alzheimers Dis. 82:1683. PubMed
  211. Shimada H, et al. 2022. Cell Rep Methods. 2:100289. PubMed
  212. Neddens J, et al. 2020. PLoS One. 15:e0235543. PubMed
  213. Huang L, et al. 2020. Cell Death Dis. 1.033333333. PubMed
  214. Pan H, et al. 2016. Stem Cell Reports. 7:707-718. PubMed
  215. Fu A, et al. 2016. Proc Natl Acad Sci U S A. 113: 2705 - 2713. PubMed
  216. Michno W, et al. 2020. Journal of Neurochemistry. 152(5):602-616.. PubMed
  217. Buccarello L, et al. 2017. Oncotarget. 8:83038. PubMed
  218. Tambini MD, et al. 2020. J Biol Chem. 295:7442. PubMed
  219. Chernick D, et al. 2018. J Neurochem. 147:647. PubMed
  220. Spitzer P, et al. 2018. Front Aging Neurosci. 10:152. PubMed
  221. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  222. Dyer M, et al. 2019. Front Aging Neurosci. 11:68. PubMed
  223. Rosenzweig N, et al. 2019. Nat Commun. 10:465. PubMed
  224. Piccirillo S, et al. 2022. Cell Death Discov. 8:391. PubMed
  225. Stimmell AC, et al. 2021. Front Aging. 2:. PubMed
  226. Cuddy LK, et al. 2022. Mol Neurodegener. 17:54. PubMed
  227. Guo M, et al. 2022. Acta Pharm Sin B. 12:1723. PubMed
  228. Kaldun JC, et al. 2021. PLoS Biol. 19:e3001412. PubMed
  229. Kaneshiro N, et al. 2022. iScience. 25:103869. PubMed
  230. Xie C, et al. 2022. Nat Biomed Eng. 6:76. PubMed
  231. Zhang J, et al. 2021. iScience. 24:103327. PubMed
  232. Machhi J, et al. 2021. J Neuroinflammation. 18:272. PubMed
  233. Flanagan M, et al. 2017. J Neuropathol Exp Neurol. 10.1093/jnen/nlw104. PubMed
  234. Yang S, et al. 2017. EMBO Mol Med. 9(1):61-77. PubMed
  235. Sri S, et al. 2019. Acta Neuropathol Commun. 7:25. PubMed
  236. Lim CS, et al. 2018. Biosci Rep. 38:1. PubMed
  237. Fowler AJ, et al. 2019. Drugs R D. 19:149. PubMed
  238. Xu L et al. 2019. Cell reports. 27(4):1293-1306 . PubMed
  239. Gulisano W, et al. 2019. J Neurosci. 39:5986. PubMed
  240. Yadav DB, et al. 2017. Br J Pharmacol. 174:4173. PubMed
  241. Merlini M et al. 2019. Neuron. 101(6):1099-1108 . PubMed
  242. Cline EN, et al. 2019. J Neurochem. 148:822. PubMed
  243. Sheng L, et al. 2019. FASEB J. 33:10425. PubMed
  244. Pi G, et al. 2020. Nat Commun. 0.585416667. PubMed
  245. Wang D, et al. 2018. Neurosci Bull. 34:912. PubMed
  246. Griner SL, et al. 2020. eLife. 8:e46924.. PubMed
  247. Shippy DC, et al. 2020. J Neuroinflammation. 0.902777778. PubMed
  248. Mackenzie-Gray Scott CA, et al. 2022. Front Synaptic Neurosci. 14:857608. PubMed
  249. Tsai AP, et al. 2021. Neurobiol Dis. 153:105303. PubMed
  250. Na H, et al. 2020. Neuropharmacology. 108017:168. PubMed
  251. Reinders N, et al. 2016. Proc Natl Acad Sci U S A. 113: E6526 - E6534. PubMed
  252. Miyamoto T, et al. 2016. J Biol Chem. 291: 1719 - 1734. PubMed
  253. Sandoval-Hernández A, et al. 2015. PLoS One. 10: 0145467. PubMed
  254. Wang S, et al. 2019. Sci Rep. 9:19575. PubMed
  255. Hansson O, et al. 2019. Alzheimers Res Ther. 0.51875. PubMed
  256. Rubio–Araiz A, et al. 2018. J Neuroinflammation. 0.796527778. PubMed
  257. Harper MM, et al. 2019. Invest Ophthalmol Vis Sci. 60:2716. PubMed
  258. Grant MKO, et al. 2019. Biol Proced Online. 21:6. PubMed
  259. Casali BT, et al. 2018. J Neuroinflammation. 15:43. PubMed
  260. Zhu B, et al. 2022. Chem Sci. 13:8104. PubMed
  261. Lim JY, et al. 2022. Cells. 11:. PubMed
  262. Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed
  263. Yuan X, et al. 2020. J Alzheimers Dis. 78:425. PubMed
  264. Reed-Geaghan EG, et al. 2020. J Exp Med. 217:00:00. PubMed
  265. Colombo AV, et al. 2021. eLife. 10:00. PubMed
  266. Chen WT, et al. 2020. Cell. 182(4):976-991.e19. PubMed
  267. La Barbera L, et al. 2021. Progress in Neurobiology. 202:102031. PubMed
  268. Yu XL, et al. 2020. Br J Pharmacol. 177:2860. PubMed
  269. Faraz A, et al. 2017. Antioxid Redox Signal. . 10.1089/ars.2016.6860. PubMed
  270. Matthes F, et al. 2018. Cell Death Discov. 4:4. PubMed
  271. Datta M, et al. 2018. Immunity. 48:514. PubMed
  272. Vargas–Restrepo F, et al. 2018. Biomedica. 38:69. PubMed
  273. Di Fede G, et al. 2018. Sci Rep. 2.603472222. PubMed
  274. Prakash P, et al. 2019. Methods Protoc. 2:48. PubMed
  275. Pires G, et al. 2019. Acta Neuropathol Commun. 0.427083333. PubMed
  276. Batarseh YS, et al. 2017. Neuroscience. 352:204. PubMed
  277. Van der Jeugd A, et al. 2018. Sci Rep. 8:6431. PubMed
  278. Tao L, et al. 2021. Light Sci Appl. 10:179. PubMed
  279. Kwon OH, et al. 2021. Membranes (Basel). 11:. PubMed
  280. Hao X, et al. 2022. Front Immunol. 13:816640. PubMed
  281. Rani K, et al. 2021. J Neurosci Methods. 347:108980. PubMed
  282. Henningfield CM, et al. 2022. Glia. 70:287. PubMed
  283. Bourdenx M, et al. 2021. Cell. 184(10):2696-2714.e25. PubMed
  284. Lackie RE, et al. 2020. Acta Neuropathol Commun. 0.432638889. PubMed
  285. Hernandez-Rapp J, et al. 2016. Sci Rep. 6:30953. PubMed
  286. Li S, et al. 2020. Front Immunol. 11:49. PubMed
  287. Sachdev R, et al. 2018. Mol Neurobiol. 55:8355. PubMed
  288. Esquerda–Canals G, et al. 2019. PLoS One. 14:e0217793. PubMed
  289. Kiyota T, et al. 2018. J Neuroimmunol. 319:80. PubMed
  290. Ahmad F et al. 2018. Scientific reports. 8(1):13119 . PubMed
  291. Kim W, et al. 2018. Mol Neurodegener. 13:6. PubMed
  292. Kageyama Y, et al. 2021. ACS Chem Neurosci. 12:3419. PubMed
  293. Morabito S, et al. 2021. Nat Genet. 53:1143. PubMed
  294. Maiti P, et al. 2020. Int J Mol Sci. 21:. PubMed
  295. Sadleir KR, et al. 2022. PLoS One. 17:e0263332. PubMed
  296. Sankowski R, et al. 2021. EMBO J. 40:e108605. PubMed
  297. Bassil R, et al. 2021. Nat Commun. 12:5220. PubMed
  298. Amin L, et al. 2021. Nat Commun. 12:3451. PubMed
  299. Cen X, et al. 2020. Nat Commun. 4.438194444. PubMed
  300. Cho YY, et al. 2020. Molecules. 25:00:00. PubMed
  301. Hung C, et al. 2021. Cell Reports. 35(11):109259. PubMed
  302. Pérez MJ, et al. 2020. Mol Psychiatry. . PubMed
  303. Chen W, et al. 2020. J Neurosci. 8188:40. PubMed
  304. Ma Y, et al. 2020. J Proteome Res. . PubMed
  305. Chen L, et al. 2017. Sci Rep. 10.1038/s41598-017-12484-3. PubMed
  306. Hung COY et al. 2018. Cell reports. 25(13):3647-3660 . PubMed
  307. Amar F, et al. 2017. Sci Signal. 10:478. PubMed
  308. Chandra S, et al. 2019. J Alzheimers Dis Rep. 3:149. PubMed
  309. Jonson M, et al. 2018. Cell Chem Biol. 25:595. PubMed
  310. Ding Y, et al. 2019. Front Neurol. 1.208333333. PubMed
  311. Lee HT, et al. 2019. J Neuroinflammation. 0.852083333. PubMed
  312. Hu T, et al. 2020. Aging (Albany NY). 0.834027778. PubMed
  313. Kaya I, et al. 2017. ACS Chem Neurosci. 8:347. PubMed
  314. Chen X, et al. 2020. Nat Commun. 11:867. PubMed
  315. Goodman JR, et al. 2018. Brain Behav Immun. 73:34:00. PubMed
  316. Xu P, et al. 2021. J Exp Med. 218: . PubMed
  317. Emre C, et al. 2021. Acta Neuropathol Commun. 9:116. PubMed
  318. Pauls E, et al. 2021. Genome Med. 13:168. PubMed
  319. Ledo JH, et al. 2020. Mol Psychiatry. . PubMed
  320. Salta E, et al. 2016. EMBO Mol Med. 8: 1005 - 1018. PubMed
  321. An Y, et al. 2020. Front Immunol. 11:162. PubMed
  322. Yan T, et al. 2020. Nat Commun. 0.74375. PubMed
  323. van Husen LS, et al. 2019. J Alzheimers Dis. 72:537. PubMed
  324. Keene CD, et al. 2019. Lab Invest. 99:1056. PubMed
  325. Park JS, et al. 2018. Sensors (Basel). 18:00. PubMed
  326. Welty S, et al. 2018. J Biol Chem. 293:1353. PubMed
  327. López–Arias B, et al. 2017. PLoS One. 12:e0177541. PubMed
  328. Maharjan S, et al. 2022. Front Neurosci. 16:964654. PubMed
  329. Catania M, et al. 2022. Mol Psychiatry. :. PubMed
  330. Ohline SM, et al. 2022. Mol Brain. 15:5. PubMed
  331. Herrmann F, et al. 2021. Sci Rep. 11:17977. PubMed
RRID
AB_2715854 (BioLegend Cat. No. 803004)
AB_2564653 (BioLegend Cat. No. 803001)
AB_2564654 (BioLegend Cat. No. 803002)
AB_2564652 (BioLegend Cat. No. 803003)

Antigen Details

Structure
Amyloid precursor protein is a 770 amino acid protein with a molecular mass of ~100 kD. According to the UniProtKB database, APP (ID# P05067) has 11 isoforms (34 to ~90 kD) and the 770 form has been designated as the canonical form. Isoform APP695 is the predominant form expressed in neuronal tissue. Isoforms APP751 and APP770 are widely expressed in non-neuronal cells. Isoform APP751 is the most abundant form in T-lymphocytes. Aβ denotes peptides of 36-43 amino acids generated from cleavage of APP by secretases. Aβ has an apparent molecular mass of about 4 kD.
Distribution

Tissue distribution: Primarily nervous system, but also adipose tissue, intestine, muscle.
Cellular distribution: Cytosol, endosomes, nucleus, plasma membrane, extracellular, and golgi apparatus.

Function
The normal function of Aβ is not well understood. Several potential physiological roles have been proposed, including: activation of kinase enzymes; protection against oxidative stress; regulation of cholesterol transport; transcription factor, and as an anti-microbial agent.
Biology Area
Cell Biology, Neurodegeneration, Neuroscience, Protein Misfolding and Aggregation
Molecular Family
APP/β-Amyloid
Antigen References
  1. Kumar A, et al. 2015. Pharmacol. Rep. 67(2):195.
  2. Sadigh-Eteghad S, et al. 2015. Med. Princ. Pract. 24(1):1
  3. Hampel H, et al. 2015. Expert Rev. Neurother. 15(1):83.
  4. Puig KL, et al. 2012.  Exp. Gerontol. 48(7): 608.
  5. Selkoe DJ, et al. 2016. EMBO Mol. Med. 8(6):595.
  6. Walsh DM, et al.  2007. J. Neurochem. 101(5):1172.
Gene ID
351 View all products for this Gene ID
UniProt
View information about beta-Amyloid, 1-16 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 03/12/2021

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Alexa Fluor® 488 anti-β-Amyloid, 1-16

  • Anti-β-Amyloid, 1-16

  • Biotin anti-β-Amyloid, 1-16

  • Purified anti-β-Amyloid, 1-16

  • HRP anti-β-Amyloid, 1-16

  • Alexa Fluor® 594 anti-β-Amyloid, 1-16

  • Alexa Fluor® 647 anti-β-Amyloid, 1-16

  • Ultra-LEAF™ Purified anti-β-Amyloid, 1-16

  • Spark YG™ 570 anti-β-Amyloid, 1-16

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account